Pet owners share the financial hoops they’ve jumped through for their cats and dogs — from taking out loans and eating ramen ...

Dear Quentin, When I leave my job, would I be better off taking a $61,000 lump sum to roll over into an existing IRA or, ...

U.S. stock-market futures rose Sunday, after the S&P 500 and Nasdaq finished last week at record highs.

I take Ubers for work many times per week as I travel for my job. We’ve just been told that we are now only allowed to tip 15 ...

Debate is underway in the Senate for an all-night session Sunday, with Republicans wrestling President Donald Trump’s big ...

Republican Sen. Thom Tillis of North Carolina said Sunday he will not seek reelection next year, a day after announcing his ...

F1 The Movie” debuted with $55.6 million in North American theaters and $144 million globally over the weekend, according to ...

Last Friday, while investors focused on earnings reports and Federal Reserve tea leaves, the U.S. Supreme Court quietly handed your portfolio a gift, wrapped in constitutional law. Here’s what ...

The odds of a major decline in the U.S. stock market have just shot up, even as the S&P 500 SPX and other U.S. benchmarks are at new highs. The gold-platinum ratio is a short-term stock-market timing ...

President Donald Trump’s big tax bill in the Senate would pile trillions onto the nation’s debt load while resulting in even ...

Biogen has launched a late-stage study of its investigational drug felzartamab in the rare immune-mediated kidney disease primary membranous nephropathy, or PMN. Biogen on Monday said the phase 3 ...